The committees recommendation is non-binding, and the FDA hasnt issued a final determination
The increase was seen across all age groups, particularly among those aged 20, 30, and 80 years
WeightWatchers builds around behavior first
GLP-1 (glucagon-like peptide-1) and GLP-2 (glucagon-like peptide-2) are two related but functionally distinct gut peptides
Cigna said that for employees who had insurance approvals for the drugs, it would cover older, generic weight-loss drugs including phentermine, diethylpropion, benzphetamine and phendimetrazine, which are less effective than GLP-1s
What we know is that the active ingredient is the same, the mechanism of action is identical, and the clinical evidence for semaglutides effectiveness comes from the molecule itself rather than the delivery format